WHO Says AstraZeneca Vaccine's Benefits Outweigh Risks
Benjamin Cowling, Professor of Infectious Disease Epidemiology, University of Hong Kong
18-Mar-21 07:37
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
Several European countries like Germany and Italy have temporarily suspended the rollout of the AstraZeneca vaccines over concerns that dozens of recipients of the shot have developed blood clots. So how concerning is this in the big picture? And how might it impact the public's trust in COVID-19 vaccines? For some insight, we speak with Benjamin Cowling, Professor of Infectious Disease Epidemiology at the University of Hong Kong.
Image Credit: rafapress / Shutterstock.com
Produced by: Dayana Mustak
Presented by: Philip See, Wong Shou Ning
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Health Policy, Diseases & Conditions, Mental Health, Healthy Living, Fitness, Medical Innovation and Technology, Science, Investments
Tags: WHO, astrazeneca, covid-19, vaccine, side effects, blood clots,
